跳至主要内容
临床试验/NCT01279811
NCT01279811已完成不适用

The Canadian Multicentre CSF Monitoring and Biomarker Study

University of British Columbia8 个研究点 分布在 2 个国家目标入组 86 人开始时间: 2012年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
86
试验地点
8
主要终点
Spinal cord perfusion pressure

研究概览

简要总结

The purpose of this study is to:

  1. Measure the pressure in the spinal fluid surrounding the spinal cord to find out how well the spinal cord is being supplied with blood.
  2. Determine how drugs called "vasopressors", which are used to control blood pressure following SCI (spinal cord injury), influence spinal fluid pressure.
  3. Characterize the severity of an SCI using the levels of specific proteins found within the spinal fluid.
  4. Predict how much neurologic recovery may be regained using the levels of specific proteins within your spinal fluid.
  5. Identify proteins within the spinal fluid that will help us learn more about what is happening after SCI and assist us in developing new treatments for SCI.

详细描述

This research project consists of two complementary yet distinct initiatives:

  1. First, we will prospectively evaluate spinal cord perfusion pressure(SCPP)in patients with acute spinal cord injuries, to provide scientifically-based guidelines on the management of blood pressure during the acute injury phase.
  2. Second, we will evaluate cerebrospinal fluid(CSF) samples from these patients with the goal of prospectively validating a series of biochemical markers that correlate with injury severity and predict neurologic outcome. Ultimately, our goals are to enhance the neurologic outcome of individuals with spinal cord injuries by improving upon their acute clinical care, and to establish biological surrogates of injury severity that may be used to facilitate clinical trials of novel therapeutic interventions for acute spinal cord injury.

Specific Aims

This multicenter study will enroll patients with acute traumatic cervical and thoracic SCI within 48 hours of their injury. A lumbar intrathecal catheter will be inserted pre-operatively for the measurement of intrathecal pressure (ITP) and the collection of CSF samples. Spinal cord perfusion pressure will be calculated as the difference between mean arterial pressure (MAP) and the ITP. The objectives of this aspect of the study will be to:

  • Document the changes in SCPP over the first 5-7 days post-injury (with an intrathecal catheter that is in place for 5 days).
  • Determine the effect of different vasopressor agents on SCPP.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
17 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 17 years of age or older
  • Complete (AIS A)or incomplete (AIS B, C) acute SCI involving bony spinal levels between C0 and L1
  • Non-penetrating injury
  • Able to communicate in English and provide informed consent
  • Enrolled within 48 hours after injury and able to provide CSF and blood samples within this period

排除标准

  • SCI that involves sensory impairment only (i.e., no impairment in ability to move arms and legs)
  • Penetrating spinal cord injury
  • Isolated radiculopathy (injury only to the nerve outside of the spinal cord)
  • Cauda equina injury (injury to nerve roots at the end of the spinal cord)
  • Severe injury to head at the time of the SCI
  • Injury to lower back (below the spinal level L1)
  • Major injury to legs, arms, pelvis, chest, or abdomen that make it impossible for doctors to tell how severely injured the spinal cord is
  • Have a pre-existing neurological disorder such as Parkinson's disease, Alzheimer's disease, Huntington's disease, or multiple sclerosis or amyotrophic lateral sclerosis.
  • Pre-existing thromboembolic disease or coagulopathy (disorders related to blood clotting), such as haemophilia or von Willebrand's disease
  • Pre-existing and ongoing infection in the body (e.g., pneumonia, urinary tract infection, cellulitis)
  • Pre-existing inflammatory or autoimmune disorder such as rheumatoid arthritis, systemic lupus, psoriasis
  • Systemic disease that may interfere with safety or evaluation of the condition we're studying (e.g., heart disease, HIV, HTLV-1)
  • Any other medical condition that in the investigator's opinion would render the study procedures dangerous or impair ability to receive study therapy
  • Pregnancy

结局指标

主要结局

Spinal cord perfusion pressure

时间窗: 5 days

SCPP will be calculated as the difference between the MAP and ITP. The ITP and MAP will be recorded over 5 days(5-7 days post-injury) while the lumbar intrathecal catheter is in place.

次要结局

  • Levels of specific biochemical markers in the CSF(5 days)
  • International Standards for Neurological Classification of Spinal Cord Injury (aka ASIA Examination)(1 year)
  • DN4 and other pain questionnaires(1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Brian Kwon

Principal Investigator

University of British Columbia

研究点 (8)

Loading locations...

相似试验